WHO GMP Herbal Medicines: The Standard That Opens Over 100 Global Markets
WHO Technical Report Series 863 - Good Manufacturing Practices for Pharmaceutical Products is the primary WHO GMP herbal medicines framework adopted by national regulatory authorities across over 100 countries.
WHO GMP herbal medicines is the Good Manufacturing Practice framework published by the World Health Organization specifically for the production of herbal medicinal products and botanical extracts. The WHO guidelines herbal medicines GMP framework - set out primarily in WHO Technical Report Series (TRS) 863 and TRS 996 - is adopted as the basis for national GMP legislation by over 100 countries, making it the most globally relevant GMP standard for botanical extract producers.
If you export WHO GMP herbal extract to markets in Asia, Africa, the Middle East, or Latin America - or if you supply manufacturers who do - WHO GMP herbal medicines compliance is your commercial entry ticket. Many importers in these markets will not purchase WHO GMP botanical extract from a producer who cannot demonstrate compliance. In India, China, Iran, Nigeria, and Kenya, national GMP requirements for herbal medicines are directly grounded in the WHO guidelines herbal medicines GMP framework and carry full regulatory legal weight.
How BES ensures GMP compliance for your extraction process shows how equipment specification and documentation support WHO GMP herbal medicine extraction compliance.
WHO Guidelines Herbal Medicines GMP: Core Requirements for Botanical Extract Producers
The WHO guidelines herbal medicines GMP framework is principles-based rather than prescriptive - it defines what must be achieved, not exactly how. For WHO GMP herbal extract producers, the core requirements are:
WHO GMP Requirement | What It Means for Your WHO GMP Botanical Extract Facility |
Starting material identification | Every botanical raw material must be identified by scientific name, plant part, and geographic origin. WHO GMP herbal medicine extraction cannot begin on unidentified or unauthenticated material. |
Adulteration risk management | WHO GMP herbal extract must be produced from authenticated starting materials. DNA barcoding, TLC, or HPLC fingerprinting must be used for species at risk of adulteration or substitution. |
Pesticide and mycotoxin testing | WHO guidelines herbal manufacturing require testing or risk assessment for pesticide residues and mycotoxins in all botanical starting materials. Limits must align with WHO or pharmacopoeia standards. |
Defined extraction procedures | WHO GMP herbal medicine extraction must follow a written procedure defining solvent (if any), temperature, time, pressure, and solvent-to-material ratio for every WHO GMP botanical extract product. |
Batch documentation | A batch manufacturing record must be completed for every production batch of WHO GMP herbal extract - documenting actual parameters, yield, in-process results, and any deviations. |
Quality control testing | Every WHO GMP botanical extract batch must be tested for identity, purity, and potency against a defined specification before release. |
Qualified personnel | A person with pharmaceutical or equivalent scientific qualifications must be responsible for quality control and batch release for all WHO GMP herbal medicines produced. |
Equipment cleaning | Cleaning procedures for all WHO GMP extraction facility equipment must be documented and validated. Cross-contamination between botanical species must be prevented. |
WHO GMP Herbal Extract: Special Considerations for Botanical Starting Materials
ICH Q3C - Residual Solvents guideline applicable to WHO GMP herbal extract production defines the solvent residue limits that WHO GMP botanical extract producers must comply with when organic solvents are used in extraction.
The WHO guidelines herbal medicines GMP framework recognises that botanical starting materials present quality challenges that synthetic pharmaceutical ingredients do not. The WHO GMP herbal extract programme specifically addresses:
- Natural composition variability: a WHO GMP botanical extract specification must define active compound content and be tested on every batch - because the same species from different regions, different harvest times, or different post-harvest handling can vary significantly in composition. WHO GMP herbal medicines compliance requires this variability to be managed by standardisation, not ignored.
- Adulteration and substitution: high-value botanicals used in WHO GMP herbal extract production are targets for adulteration with cheaper species. WHO guidelines herbal manufacturing require authentication at a level appropriate to the adulteration risk - from simple macroscopic examination for low-risk materials to HPLC fingerprinting or DNA barcoding for high-risk ones.
- Solvent residues: where organic solvents are used in WHO GMP herbal medicine extraction, residue testing must confirm that the WHO GMP botanical extract meets the limits defined in ICH Q3C or equivalent. SC-CO2 extraction eliminates this obligation entirely - CO2 reverts to gas, leaving zero extractant residue.
- WHO GMP extraction facility cleanliness: the WHO guidelines herbal manufacturing framework requires that the WHO GMP extraction facility for a given botanical species is thoroughly cleaned before processing a different species. MACO calculations or validated cleaning procedures demonstrate that cross-contamination between species does not occur.
Extracting high-value organic compounds with precision using a CO2 extraction machine explains how CO2 extraction simplifies the WHO GMP herbal medicine extraction solvent residue compliance requirement.
WHO GMP Botanical Extract: How It Compares to EU GMP and FDA cGMP
WHO GMP Herbal Medicines | EU GMP (EudraLex Vol. 4) | FDA cGMP (21 CFR Part 111) | |
Legal status | Guideline - adopted into national law by WHO member states | Legally binding in EU member states | Legally binding for all US market suppliers |
Identity testing | Required - method appropriate to risk level | Required - pharmacopoeia methods preferred | 100% in-house testing of every lot mandatory |
Documentation style | Principles-based - implementation flexible | More prescriptive, specific annexes per product type | Highly prescriptive - specific formats defined |
Solvent residue | ICH Q3C or equivalent limits apply | ICH Q3C applies | ICH Q3C applies |
Facility inspection | National competent authority of manufacturer's country | EMA and national medicines agencies | US FDA - including international facilities |
Herbal-specific guidance | WHO TRS 863 Annex 11; TRS 996; WHO Technical Report 47 | Annex 7 - specific to herbal medicinal products | 21 CFR Part 111 applies to supplements broadly |
For manufacturers already operating under EU GMP or FDA cGMP, WHO GMP herbal medicines compliance typically requires documentation adaptation rather than operational overhaul. The gap is usually in whether your documents reference the relevant WHO TRS, and whether you have a WHO GMP certificate issued by your national competent authority.
WHO GMP Extraction Facility: Physical and Operational Requirements
The physical requirements for a WHO GMP extraction facility mirror the design principles covered in hygienic design principles and cGMP compliance for pharmaceutical CO2 extraction - cleanable surfaces, controlled access, and equipment design that supports cleaning validation across all WHO GMP herbal medicines operations.
The WHO GMP extraction facility must meet the following minimum requirements under the WHO guidelines herbal medicines GMP framework:
- Dedicated areas: the WHO GMP extraction facility must have separate areas for botanical raw material receipt and quarantine, weighing, WHO GMP herbal medicine extraction, post-extraction processing, quality control, and finished product storage. Physical separation is preferred; procedural separation with demonstrated contamination prevention is acceptable.
- Equipment construction: all product-contact equipment in the WHO GMP extraction facility must be made from materials that do not react with or contaminate the WHO GMP botanical extract. Stainless steel is standard. Gaskets, seals, and hoses must be chemically compatible with the extraction solvent and product.
- Cleaning records: written cleaning procedures and records demonstrating that the WHO GMP extraction facility equipment was cleaned before each production campaign. For multi-species WHO GMP herbal extract facilities, MACO calculations demonstrating safe carryover limits.
- Calibration: all measuring instruments in the WHO GMP extraction facility - temperature, pressure, flow, balance - calibrated at defined intervals with calibration records maintained.
WHO Guidelines Herbal Manufacturing: Getting Your WHO GMP Certificate
WHO Prequalification Programme for medicines - facility assessment requirements describes the WHO PQ inspection process that WHO GMP herbal medicine manufacturers must meet to access procurement-driven markets.
WHO GMP certification for WHO GMP herbal medicine extraction is issued by the national competent authority of the manufacturer's country - not by WHO directly. The WHO guidelines herbal manufacturing framework sets the standard; the national authority inspects and certifies:
- India: State Licensing Authority (SLA) under Schedule M of the Drugs and Cosmetics Rules. WHO GMP herbal extract certificate for pharmaceutical-grade botanical extracts.
- China: National Medical Products Administration (NMPA) GMP certificate under Chinese GMP regulations aligned with WHO guidelines herbal manufacturing principles.
- WHO Prequalification: for WHO GMP botanical extract products targeting WHO procurement or markets requiring WHO PQ - an independent WHO assessment of product dossier and WHO GMP extraction facility.
The first step toward WHO GMP herbal medicines certification is ensuring your facility, procedures, and documentation meet the WHO guidelines herbal medicines GMP requirements. Then apply to your national competent authority for inspection and certification.
Where Buffalo Extraction Systems Fits In
Buffalo Extraction Systems manufactures extraction and pre-processing equipment designed to support WHO GMP herbal medicine extraction compliance. CE certified, SS316L contact surfaces, SCADA control with data logging, CIP-compatible design, and IQ/OQ/PQ documentation packages - covering the equipment side of WHO GMP extraction facility requirements across all three capacity scales: 200, 500, and 1,000 kg/hr dry output.
Conclusion
WHO GMP herbal medicines is the quality framework that opens botanical extract producers to over 100 global markets. WHO GMP herbal extract compliance - covering botanical starting material authentication, WHO GMP herbal medicine extraction procedure documentation, batch records, and quality control testing - follows the same principles as EU GMP and FDA cGMP with a more flexible, principles-based implementation style. The WHO guidelines herbal medicines GMP framework is not more lenient than EU or FDA GMP - it is simply adopted at the national level by a wider range of regulatory authorities. For any WHO GMP botanical extract producer targeting emerging-market pharmaceutical and nutraceutical customers, WHO GMP certification from your national competent authority is the commercial credential that cannot be substituted.
Frequently Asked Questions
What is WHO GMP herbal medicines?
WHO GMP herbal medicines refers to the Good Manufacturing Practice framework published by the WHO (primarily in TRS 863 and TRS 996) for the production of herbal medicinal products and botanical extracts. The WHO guidelines herbal medicines GMP framework is adopted as national GMP law by over 100 countries, particularly in Asia, Africa, Latin America, and the Middle East. It is the most globally relevant GMP standard for WHO GMP herbal extract producers.
What does WHO GMP herbal extract compliance require?
WHO GMP herbal extract compliance requires: botanical starting material identification by scientific name, plant part, and geographic origin; adulteration authentication appropriate to the species risk level; pesticide and mycotoxin testing; written WHO GMP herbal medicine extraction procedures; batch manufacturing records for every production run; QC testing of every batch before release; qualified personnel; and WHO GMP extraction facility cleaning records with MACO calculations for multi-species operations.
How does WHO GMP botanical extract compliance compare to EU GMP?
Both share the same core requirements. EU GMP (EudraLex Volume 4) is legally binding in EU member states and more prescriptive in documentation format. WHO GMP herbal medicines is a guideline adopted into national law by WHO member states - more flexible in implementation. If you are EU GMP certified, achieving WHO GMP botanical extract compliance typically requires documentation adaptation and a WHO GMP certificate from your national authority rather than operational changes.
What are WHO GMP extraction facility requirements?
WHO GMP extraction facility requirements: dedicated areas for receipt, quarantine, weighing, WHO GMP herbal medicine extraction, QC, and storage; stainless steel product-contact surfaces chemically compatible with the extraction solvent; documented cleaning procedures and records; calibrated instruments for all critical parameters; and - for multi-species facilities - MACO calculations demonstrating safe cross-contamination limits between botanical species.
How do I get a WHO GMP herbal medicines certificate?
WHO GMP certification is issued by your national competent authority - not by WHO directly. In India: State Licensing Authority under Schedule M. In China: NMPA. For WHO Prequalification covering specific product types: apply to the WHO PQ programme for independent assessment of your product dossier and WHO GMP extraction facility. The process begins with ensuring your facility and quality system meet the WHO guidelines herbal medicines GMP requirements.
